United States · 
What does The Cynosure Group invest in?
The Cynosure Group invests most often at Growth (100% of the rounds on record), in sectors such as Biotechnology and Health Diagnostics.
The Cynosure Group highlights
- 01
2 cheques in the last 12 months
- 02
Mostly Growth: 100% of its rounds
What they do
Filed 4 private fund offerings with the SEC, the most recent in 2024-03From their own website
- Type
- Private equity (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries B
- Sectors
- BiotechnologyHealth Diagnostics
- Based in
- Salt Lake City, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first2 appearances
- 2026
2 rounds
- Oct
- Oct
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration12 named
AKAndrew Keith BraithwaiteExecutive Officer, DirectoriFiling they signed
CHClista Hope EcclesMemberiForm ADV
DCDavid CheckettsExecutive Officer, DirectoriFiling they signed
EMEmily Marva TeranChief Compliance OfficeriForm ADV
HEHerbert E. ScruggsExecutive Officer, DirectoriFiling they signed
LELisa Ellen EcclesMember/OwneriForm ADV
MKMark Keith OligschlaegerExecutive Officer, DirectoriFiling they signed
RKRandal Keith QuarlesExecutive Officer, DirectoriFiling they signed
RKRandall K. QuarlesExecutive Officer, DirectoriFiling they signed
RGRichard Grant LeeChief Financial OfficeriForm ADV
RKRichard Keith TaylorManaging Director of the Managing Member of the General Partner of the Issuer, Managing Director of the Investment ManageriFiling they signed
SPSpencer Peterson EcclesManaging Director/Member/OwneriForm ADV
We also hold 19 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$9.8Bassets it managesOct 2026
Registeredinvestment adviserfull reporting to the SEC
- Legal name
- The Cynosure Group
- SEC number
- CRD 281399
Funds on its Form ADV
45 private funds, $2.7B in gross assets · filed Dec 2024
Private equity 25Private credit 10Venture 4
- Cynosure Partners 2020, L.P.Private equity139 investors$630M
- Cynosure Partners III, L.P.Private equity104 investors$522M
- Cynosure Partners 2020 Co-Investment, LLC Series CPrivate equity91 investors$206M
- Cynosure Investment Partners, LLC - 2020 Absolute IncomePrivate credit21 investors$160M
- Cynosure Investment Partners, LLC - 2021 Diversified IncomePrivate credit7 investors$149M
- Cynosure Investment Partners, LLC - 2019 StewardPrivate equity38 investors$116M
- Cynosure Wealth Partners, LLC - Classes SC-1 and SC-2Private equity29 investors$83M
- Cynosure Investment Partners, LLC - 2022 FS GrowthVenture64 investors$65M
- Cynosure Avalon Buildgroup, LLCPrivate credit108 investors$64M
- Cynosure Investment Partners, LLC - 2019 SG CreditPrivate equity50 investors$61M
And 35 more on the filing.